Agenus shared a post on LinkedIn:
A powerful reminder of why clinical research matters.
This story highlights the promise of immunotherapy for patients with colorectal cancer – and the real lives behind the science.
At Agenus, we are grateful to investigators like Nicholas DeVito, MD and partners like the Gateway for Cancer Research for advancing innovative studies such as the BBOpCo trial, helping bring new immunotherapy approaches to patients who urgently need better options.
Clinical trials turn scientific discovery into real patient impact. Every patient who participates moves the field forward.
This is why we do what we do.
Watch the story from CBS News below.”
Other articles about Agenus on OncoDaily.